News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Continue Reading Previous Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive OfficerNext EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 Related Stories News Waldencast announces conclusion of SEC investigation News Leading CDMO Selects Kneat to Power Digital Validation Transformation News Chetu Hosts Free Executive Webinar: ‘Digital Transformation in Healthcare’ News IC Manage Advances GDP-AI for Custom IC Design with Virtuoso News Non-followers Now Drive More Views Than Followers, According to Dash Social News Groove Brings All-In-One PropTech Solutions to Incite Strategic Members Through New Partnership